4.7 Article

Different HBsAg Decline After 3 years of Therapy with Entecavir in Patients Affected by Chronic Hepatitis B HBeAg-Negative and Genotype A, D and E

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

George Papatheodoridis et al.

JOURNAL OF HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

Quantitative Hepatitis B Surface Antigen Levels in Patients With Chronic Hepatitis B After 2 Years of Entecavir Treatment

James Fung et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Surrogate End Points and Long-Term Outcome in Patients With Chronic Hepatitis B

Vincent Wai-Sun Wong et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)

Article Pharmacology & Pharmacy

Predictors of Treatment Response in Chronic Hepatitis B

Grace L-H. Wong et al.

DRUGS (2009)

Article Gastroenterology & Hepatology

Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a

Patrick Marcellin et al.

GASTROENTEROLOGY (2009)

Review Virology

Hepatitis B virus: the genotype E puzzle

Iris E. Andernach et al.

REVIEWS IN MEDICAL VIROLOGY (2009)

Article Gastroenterology & Hepatology

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response

Henry Lik-Yuen Chan et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)